Literature DB >> 9242441

Retinoblastoma binding factor 1 site in the core promoter region of the human RB gene is activated by hGABP/E4TF1.

Y Sowa1, Y Shiio, T Fujita, T Matsumoto, Y Okuyama, D Kato, J Inoue, J Sawada, M Goto, H Watanabe, H Handa, T Sakai.   

Abstract

We previously reported two oncogenic point mutations present in the RB (retinoblastoma) gene promoter region, found at consensus Sp1 and ATF sites, respectively, and in two separate hereditary RB families. However, Sp1 protein was shown not to bind to the Sp1 site; this indicated that the Sp1 consensus site mutation was blocking the action of an alternative transcription factor, which we called RBF-1 (retinoblastoma binding factor 1). Subsequent purification of RBF-1 revealed it to be hGABP/E4TF1, a transactivator from the adenovirus early-region 4 promoter. In this study, we directly examined the effects of hGABP/E4TF1 on transactivation of the RB gene promoter through the RBF-1 site. As expected, hGABP/E4TF1 enhanced the core RB promoter activity, whereas it did not stimulate a mutant RBF-1 site. We therefore conclude that the most essential transcription factor in the human RB gene is likely to be hGABP/E4TF1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9242441

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Sequence-specific transcriptional repression by an MBD2-interacting zinc finger protein MIZF.

Authors:  Masayuki Sekimata; Yoshimi Homma
Journal:  Nucleic Acids Res       Date:  2004-01-29       Impact factor: 16.971

2.  Identification of a crucial site for synoviolin expression.

Authors:  Kaneyuki Tsuchimochi; Naoko Yagishita; Satoshi Yamasaki; Tetsuya Amano; Yukihiro Kato; Ko-ichi Kawahara; Satoko Aratani; Hidetoshi Fujita; Fengyun Ji; Akiko Sugiura; Toshihiko Izumi; Asako Sugamiya; Ikuro Maruyama; Akiyoshi Fukamizu; Setsuro Komiya; Kusuki Nishioka; Toshihiro Nakajima
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

3.  GABPbeta2 is dispensible for normal lymphocyte development but moderately affects B cell responses.

Authors:  Xuefang Jing; Dong-Mei Zhao; Thomas J Waldschmidt; Hai-Hui Xue
Journal:  J Biol Chem       Date:  2008-07-15       Impact factor: 5.157

4.  Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors.

Authors:  Bu-Nam Jeon; Jung-Yoon Yoo; Won-Il Choi; Choong-Eun Lee; Ho-Geun Yoon; Man-Wook Hur
Journal:  J Biol Chem       Date:  2008-09-18       Impact factor: 5.157

5.  Visualizing dynamic E2F-mediated repression in vivo.

Authors:  Monica Agromayor; Elzbieta Wloga; Benedetta Naglieri; John Abrashkin; Kapil Verma; Lili Yamasaki
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

6.  The ETS transcription factor GABPalpha is essential for early embryogenesis.

Authors:  Sika Ristevski; Debra A O'Leary; Anders P Thornell; Michael J Owen; Ismail Kola; Paul J Hertzog
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

7.  Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.

Authors:  K Verhoef; R W Sanders; V Fontaine; S Kitajima; B Berkhout
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

8.  GA-binding protein is dispensable for neuromuscular synapse formation and synapse-specific gene expression.

Authors:  Alexander Jaworski; Cynthia L Smith; Steven J Burden
Journal:  Mol Cell Biol       Date:  2007-05-07       Impact factor: 4.272

9.  Specificity protein 4 functionally regulates the transcription of NMDA receptor subunits GluN1, GluN2A, and GluN2B.

Authors:  Anusha Priya; Kaid Johar; Margaret T T Wong-Riley
Journal:  Biochim Biophys Acta       Date:  2013-07-18

10.  Targeting the GA binding protein beta1L isoform does not perturb lymphocyte development and function.

Authors:  Hai-Hui Xue; Xuefang Jing; Julie Bollenbacher-Reilley; Dong-Mei Zhao; Jodie S Haring; Baoli Yang; Chengyu Liu; Gail A Bishop; John T Harty; Warren J Leonard
Journal:  Mol Cell Biol       Date:  2008-04-21       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.